Q2
CPIX — Q2 2026 Financial Report Analysis
Cumberland's last quarter as a drug seller: legacy brand sales fell 40% and the net loss widened to $4.3M before it sold every approved product to Apotex for $100M on July 1 and paid a $1.50 special dividend.